Sort
35,931 grants matching “parkinsons”
Investigations of Dementia in Parkinson Disease
$1,574,996Joel Synes Perlmutter · Washington University · R01 · FY2021 · NS
High-Resolution Tandem Mass Spectrometer to Support Large Molecule Structural Characterization
$1,574,994Joseph A Loo · University Of California Los Angeles · S10 · FY2025 · OD
Development of a novel, regenerative therapy to reverse synapse loss in Alzheimer's Disease
$1,574,900Peter W Vanderklish · Spinogenix, Inc. · R44 · FY2024 · AG
Parkinson Disease Collaborative Study of Genetic Linkage
$1,574,654Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2007 · NS
Fluorescent Redox Indicators to Image Oxidative Stress in Alzheimer's Disease
$1,573,788Huiwang Ai · University Of Virginia · RF1 · FY2022 · AG
PARKINSON'S DISEASE RESEARCH CENTER AT COLUMBIA
$1,573,609Columbia University Health Sciences · P50 · FY2000 · NS
Parkinson Disease Collaborative Study of Genetic Linkage
$1,573,470Tatiana M. Foroud · Indiana University Indianapolis · R01 · FY2008 · NS
Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinson's Disease
$1,573,135Harrison Carroll Walker · University Of Alabama At Birmingham · UH3 · FY2020 · NS
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets
$1,572,782Aaron D. Gitler · Stanford University · U54 · FY2025 · NS
Molecular Characterization Of The Mitochondrial Dna Polymerase
$1,572,733William Copeland · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
The North American Mitochondrial Disease Consortium (NAMDC)
$1,571,080Michio Hirano · Columbia University Health Sciences · U54 · FY2023 · NS
HUCBC modulation of Alzheimer's-like pathology and behavioral changes
$1,569,916Jun Tan · Saneron Ccel Therapeutics, Inc. · R42 · FY2011 · AG
IDENTIFICATION OF CELL-TYPE SPECIFIC POST-TRANSLATIONAL MODIFICATIONS AND ALTERED SYNAPTIC PROTEIN EXPRESSION INVOLVED IN PARKINSON'S DISEASE
$1,569,750Michael Stern Parkinson'S Research Foundation, The · · FY2010 · Department of the Army
Biomarkers of Parkinson Disease and Related Disorders
$1,568,754David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
Basal Ganglia in Health and Disease
$1,568,065Guohong Cui · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Parkinson Disease Collaborative Study of Genetic Linkage
$1,567,866Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2005 · NS
Protein Phosphorylation And Regulation Of Cytoskeleton In Neuronal Systems
$1,565,557Harish C Pant · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
La Jolla-Parkinson's Disease Center Grant
$1,563,791Stuart A Lipton · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · ES
Mechanisms of PhIP-induced dopaminergic neurotoxicity
$1,563,395Jason R Cannon · Purdue University · R01 · FY2023 · ES
Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling
$1,559,994Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
Neuropathology of CTE and Delayed Effects of TBI: Toward In-Vivo Diagnostics
$1,559,550Wayne A Gordon · Icahn School Of Medicine At Mount Sinai · U01 · FY2014 · NS
Coordination and Statistics for CoQ10 in HD [2CARE]
$1,559,458Michael P McDermott · University Of Rochester · R01 · FY2008 · NS
Alpha Synuclein, cellular dysfunction and Parkinson disease
$1,559,033Mark Cookson · National Institute On Aging · ZIA · FY2019 · AG
A cellular atlas of the primate and human basal ganglia
$1,558,618Evan Z Macosko · Broad Institute, Inc. · U01 · FY2021 · MH
GTPase function of Leucine rich repeat kinase 2
$1,558,002Mark Cookson · National Institute On Aging · ZIA · FY2020 · AG